Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
European Journal of Cancer (Oxford, England : 1990)|August 6, 2024
Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trialsConnor Lynch, Mark C Korpics, Rohan R Katipally, et al.
Lung Cancer (Amsterdam, Netherlands)|October 4, 2021
Veliparib and nivolumab in combination with platinum doublet chemotherapy in patients with metastatic or advanced non-small cell lung cancer: A phase 1 dose escalation studyJeffrey M Clarke, Jyoti D Patel, Francisco Robert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinib and celecoxibMary J Fidler, Athanassios Argiris, Jyoti D Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2025
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.3Dwight H Owen, Nofisat Ismaila, Amith Ahluwalia, et al.
The Oncologist|June 30, 2023
Phase I/II Trial of Carboplatin, Nab-paclitaxel, and Pembrolizumab for Advanced Non-Small Cell Lung Cancer: Hoosier Cancer Research Network LUN13-175Ryan D Gentzler, Nisha A Mohindra, Shadia I Jalal, et al.
Cancer|August 8, 2008
Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care centerNarissa J Nonzee, Neal A Dandade, Urjeet Patel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 27, 2012
Randomized phase 2b study of pralatrexate versus erlotinib in patients with stage IIIB/IV non-small-cell lung cancer (NSCLC) after failure of prior platinum-based therapyKaren Kelly, Christopher G Azzoli, Petr Zatloukal, et al.
Journal of the National Cancer Institute|September 14, 2014
Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centersJulian C Schink, Julia R Trosman, Christine B Weldon, et al.
The Annals of Thoracic Surgery|October 18, 2024
The Society of Thoracic Surgeons Expert Consensus on the Multidisciplinary Management and Resectability of Locally Advanced Non-small Cell Lung CancerSamuel S Kim, David T Cooke, Biniam Kidane, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 16, 2011
Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: safety and efficacy in a phase 1 trialChristopher G Azzoli, Jyoti D Patel, Lee M Krug, et al.
Pageof 12